MYGN - Myriad Genetics Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TRCH (0%) SPY (0.54%) OCGN (0.14%) MOXC (0%) MGNI (4.34%) GSAT (0%) GRWG (0%) GOED (0%) GME (0%) FURY (0%) ETSY (0%) ENG (0%) CWH (0%) CRSR (-0.38%) CPE (0%) CELH (0%) BZUN (0%) BFLY (0%) BBIG (11.64%) BA (0%) AVXL (-5.33%) AU (0%) AMPUSD (%) AMC (0%) ABNB (0%)

MYGN - Myriad Genetics

$29.89 0[0%]

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$29.89	Open
Volume		Market Cap	1.785B
Yield		Last Dividend

Day

52 Week

Myriad Genetics Inc. Shares Approach 52-...	03/11/21
Myriad Genetics Inc. shares closed today at 1.8% below its 52 week high of $31.60, giving the company a market cap of $2B. The stock is currently up ...

Myriad Genetics Inc. Shares Close in on ...	03/10/21
Myriad Genetics Inc. shares closed today at 1.7% below its 52 week high of $31.60, giving the company a market cap of $2B. The stock is currently up ...

Myriad Genetics Inc. Shares Near 52-Week...	02/19/21
Myriad Genetics Inc. shares closed today at 0.8% below its 52 week high of $31.59, giving the company a market cap of $2B. The stock is currently up ...

Myriad Genetics Inc. Shares Approach 52-...	02/12/21
Myriad Genetics Inc. shares closed today at 1.7% below its 52 week high of $31.00, giving the company a market cap of $2B. The stock is currently up ...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $MYGN

Service Name	Trader	% Success
Big Data Zhou	Zhou Academy	82.00 %	Subscribe
Symmetry Options	Symmetry Options	33.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%